Nuclear factor 1 C-type (NFIC) (NFIC)

Nuclear factor 1 C-type (NFIC) is a member of the Nuclear Factor I (NFI) family of site-specific DNA-binding proteins that play critical roles in both DNA replication and gene expression regulation [UniProt P08651]. NFIC specifically binds to the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' (CCAAT-box) found in various viral and cellular promoters, acting as either a transcriptional activator or repressor depending on the cellular context and interacting partners [NCBI Gene ID: 4782]. Biologically, NFIC is indispensable for odontogenesis, particularly in the formation of tooth roots and the differentiation of odontoblasts [PubMed: 25613714]. In the context of human disease, NFIC has been implicated in various cancers, including breast and gastric cancers, where it often modulates the epithelial-mesenchymal transition (EMT) and TGF-beta signaling pathways [PubMed: 31110244]. While NFIC is recognized as a potential therapeutic target due to its regulatory influence on cell proliferation and differentiation, there are currently no approved small-molecule drugs that directly target it, though experimental approaches using RNA interference are being explored in research settings [PubMed: 28415631]. Its role in maintaining tissue homeostasis and its involvement in multiple signaling pathways suggest that therapeutic modulation would require high specificity to avoid off-target effects [PubMed: 22431104].

Other names

NF-I/CCTFCCAAT-box-binding transcription factorTGGCA-binding proteinNuclear factor I/CNFI-C

Modulation of NFIC activity typically involves inhibiting its DNA-binding capacity or interfering with its recruitment of transcriptional co-activators or repressors to CCAAT-box motifs in target gene promoters.